Swiss National Bank’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
486,800
+49,400
+11% +$241K ﹤0.01% 1757
2026
Q1
$1.88M Hold
437,400
– – ﹤0.01% 1881
2025
Q4
$3.92M Buy
437,400
+75,600
+21% +$468K ﹤0.01% 1493
2025
Q3
$1.34M Sell
361,800
-64,900
-15% -$177K ﹤0.01% 2036
2025
Q2
$832K Hold
426,700
– – ﹤0.01% 2208
2025
Q1
$751K Hold
426,700
– – ﹤0.01% 2253
2024
Q4
$1.14M Buy
426,700
+136,600
+47% +$352K ﹤0.01% 2152
2024
Q3
$664K Buy
290,100
+24,300
+9% +$74.1K ﹤0.01% 2364
2024
Q2
$776K Buy
+265,800
New +$811K ﹤0.01% 2281
2023
Q4
– Sell
-258,100
Closed -$346K – 2586
2023
Q3
$346K Hold
258,100
– – ﹤0.01% 2572
2023
Q2
$465K Hold
258,100
– – ﹤0.01% 2547
2023
Q1
$428K Sell
258,100
-24,000
-9% -$48.6K ﹤0.01% 2560
2022
Q4
$542K Hold
282,100
– – ﹤0.01% 2554
2022
Q3
$632K Hold
282,100
– – ﹤0.01% 2501
2022
Q2
$914K Buy
282,100
+24,700
+10% +$108K ﹤0.01% 2417
2022
Q1
$1.35M Buy
257,400
+18,900
+8% +$106K ﹤0.01% 2254
2021
Q4
$2.03M Sell
238,500
-26,000
-10% -$239K ﹤0.01% 2051
2021
Q3
$2.63M Buy
264,500
+1,900
+0.7% +$17.2K ﹤0.01% 1875
2021
Q2
$2.44M Buy
+262,600
New +$2.99M ﹤0.01% 1969

Other funds holding NUVB

Swiss National Bank's NUVB Position: Q2 2026 in Review

Swiss National Bank increased its Nuvation Bio (NUVB) stake by 11% in Q2 2026, buying an estimated $241K and bringing the position to 486,800 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Swiss National Bank first reported a position in NUVB in Q2 2021 and has held it in 19 quarters since. The position peaked at $3.92M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Swiss National Bank held 486,800 shares of Nuvation Bio worth $2.77M as of Q2 2026.
  • Swiss National Bank bought 49,400 Nuvation Bio shares in Q2 2026, an estimated $241K.
  • Nuvation Bio made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1757 holding.
  • Swiss National Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 19 quarters since.
  • Swiss National Bank's Nuvation Bio position peaked at $3.92M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.